Akums Drugs & Pharmaceuticals Share Price
769.95+0.65 (+0.08%)
+66.55% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
AKUMSNSE
Akums Drugs & Pharmaceuticals Share Price
769.95+0.65 (+0.08%)
+66.55% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| 10% | 10% | 6% | 6% |
| 15% | 16% | 39% | -25% |
| - | - | - | 68% |
| 6% | 2% | 9% | 8% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
LAURUSLABS
CIPLA
DRREDDY
MANKIND
AUROPHARMA
LUPIN
AKUMS
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,746.4 | ₹424466 Cr | 35.09 | 12.07 | 62.82 | ₹11479 Cr |
| 9,023 | ₹246222 Cr | 84.18 | 34.04 | 128.41 | ₹2568 Cr |
| 4,580 | ₹176301 Cr | 80.83 | 16.72 | 97.06 | ₹2163 Cr |
| 1,124.7 | ₹112818 Cr | 25 | 9.42 | 62.53 | ₹5040 Cr |
| 2,036.9 | ₹110823 Cr | 101.36 | 6.8 | 29.25 | ₹889 Cr |
| 1,314.6 | ₹107447 Cr | 31.88 | 9.77 | 57.87 | ₹3879 Cr |
| 1,216 | ₹103471 Cr | 32.11 | 5.32 | 63.99 | ₹4196 Cr |
| 2,335 | ₹97850 Cr | 47.9 | 13.75 | 71.08 | ₹1913 Cr |
| 1,662.9 | ₹96836 Cr | 26.08 | 17.95 | 96.84 | ₹3505 Cr |
| 1,953.2 | ₹89629 Cr | 16.21 | 30.95 | 154.35 | ₹5333 Cr |
| 769.95 | ₹12091 Cr | 41.45 | 6.53 | 28.62 | ₹255 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹1167 Cr | ₹1158 Cr | ₹1160 Cr | ₹1018 Cr | ₹1024 Cr | ₹1056 Cr | ₹1010 Cr | ₹1033 Cr | ₹1019 Cr | ₹944 Cr | ₹1083 Cr | ₹1181 Cr | ₹970 Cr |
| ₹30 Cr | ₹35 Cr | ₹34 Cr | ₹32 Cr | ₹27 Cr | ₹18 Cr | ₹15 Cr | ₹13 Cr | ₹7 Cr | ₹10 Cr | ₹9 Cr | ₹7 Cr | ₹8 Cr |
| ₹1197 Cr | ₹1193 Cr | ₹1194 Cr | ₹1050 Cr | ₹1051 Cr | ₹1073 Cr | ₹1025 Cr | ₹1047 Cr | ₹1026 Cr | ₹954 Cr | ₹1092 Cr | ₹1188 Cr | ₹978 Cr |
| ₹1033 Cr | ₹1046 Cr | ₹1052 Cr | ₹961 Cr | ₹932 Cr | ₹1002 Cr | ₹934 Cr | ₹947 Cr | ₹925 Cr | ₹975 Cr | ₹1021 Cr | ₹1060 Cr | ₹1125 Cr |
| ₹205 Cr | ₹187 Cr | ₹181 Cr | ₹127 Cr | ₹156 Cr | ₹111 Cr | ₹136 Cr | ₹135 Cr | ₹135 Cr | ₹13 Cr | ₹102 Cr | ₹159 Cr | -₹117 Cr |
| ₹25 Cr | ₹24 Cr | ₹24 Cr | ₹23 Cr | ₹23 Cr | ₹5 Cr | ₹5 Cr | ₹12 Cr | ₹13 Cr | ₹12 Cr | ₹12 Cr | ₹14 Cr | ₹12 Cr |
| ₹139 Cr | ₹121 Cr | ₹100 Cr | ₹66 Cr | ₹96 Cr | ₹75 Cr | ₹91 Cr | ₹92 Cr | ₹87 Cr | -₹33 Cr | ₹59 Cr | ₹87 Cr | -₹159 Cr |
| ₹101 Cr | ₹81 Cr | ₹68 Cr | ₹43 Cr | ₹65 Cr | ₹150 Cr | ₹66 Cr | ₹67 Cr | ₹61 Cr | -₹39 Cr | ₹195 Cr | ₹33 Cr | -₹187 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹31 Cr | ₹31 Cr | ₹29 Cr | ₹29 Cr | ₹14 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| ₹3283 Cr | ₹3016 Cr | ₹681 Cr | ₹689 Cr | ₹608 Cr | ₹884 Cr | ₹721 Cr | ₹855 Cr | ₹794 Cr | ₹710 Cr | ₹628 Cr | ₹493 Cr | ₹457 Cr |
| ₹3283 Cr | ₹3016 Cr | ₹681 Cr | ₹689 Cr | ₹608 Cr | ₹884 Cr | ₹721 Cr | ₹855 Cr | ₹794 Cr | ₹710 Cr | ₹628 Cr | ₹493 Cr | ₹457 Cr |
| ₹3313 Cr | ₹3047 Cr | ₹709 Cr | ₹717 Cr | ₹622 Cr | ₹885 Cr | ₹722 Cr | ₹856 Cr | ₹795 Cr | ₹711 Cr | ₹629 Cr | ₹494 Cr | ₹458 Cr |
| ₹18 Cr | ₹17 Cr | ₹11 Cr | ₹6 Cr | ₹3 Cr | ₹2 Cr | -₹2 Cr | ₹35 Cr | ₹29 Cr | ₹21 Cr | ₹12 Cr | ₹3 Cr | ₹1 Cr |
| ₹0 | ₹0 | ₹78 Cr | ₹115 Cr | ₹13 Cr | ₹0 | ₹10 Cr | ₹45 Cr | ₹17 Cr | ₹0 | ₹52 Cr | ₹78 Cr | ₹18 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹1 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹6 L | ₹0 | ₹0 |
| -₹153 Cr | -₹189 Cr | -₹111 Cr | -₹6 Cr | ₹20 Cr | ₹27 Cr | ₹33 Cr | ₹35 Cr | ₹34 Cr | ₹21 Cr | ₹39 Cr | ₹25 Cr | ₹25 Cr |
| ₹955 Cr | ₹102 Cr | ₹1464 Cr | ₹1111 Cr | ₹1095 Cr | ₹637 Cr | ₹524 Cr | ₹12 Cr | ₹11 Cr | ₹5 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr |
| ₹49 Cr | ₹36 Cr | ₹31 Cr | ₹26 Cr | ₹24 Cr | ₹20 Cr | ₹19 Cr | ₹26 Cr | ₹25 Cr | ₹24 Cr | ₹26 Cr | ₹23 Cr | ₹21 Cr |
| ₹850 Cr | -₹52 Cr | ₹1462 Cr | ₹1246 Cr | ₹1153 Cr | ₹685 Cr | ₹586 Cr | ₹118 Cr | ₹85 Cr | ₹50 Cr | ₹123 Cr | ₹133 Cr | ₹70 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹602 Cr | ₹643 Cr | ₹532 Cr | ₹567 Cr | ₹590 Cr | ₹341 Cr | ₹423 Cr | ₹210 Cr | ₹244 Cr | ₹147 Cr | ₹151 Cr | ₹153 Cr | ₹122 Cr |
| ₹345 Cr | ₹180 Cr | ₹253 Cr | ₹246 Cr | ₹238 Cr | ₹84 Cr | ₹110 Cr | ₹119 Cr | ₹85 Cr | ₹79 Cr | ₹104 Cr | ₹83 Cr | ₹46 Cr |
| ₹73 Cr | ₹14 Cr | ₹368 Cr | ₹388 Cr | ₹338 Cr | ₹86 Cr | ₹130 Cr | ₹182 Cr | ₹143 Cr | ₹183 Cr | ₹136 Cr | ₹156 Cr | ₹139 Cr |
| ₹74 Cr | ₹58 Cr | ₹58 Cr | ₹65 Cr | ₹107 Cr | ₹68 Cr | ₹67 Cr | ₹14 Cr | ₹8 Cr | ₹8 Cr | ₹7 Cr | ₹20 Cr | ₹7 Cr |
| ₹1095 Cr | ₹894 Cr | ₹1211 Cr | ₹1266 Cr | ₹1272 Cr | ₹580 Cr | ₹730 Cr | ₹525 Cr | ₹480 Cr | ₹417 Cr | ₹396 Cr | ₹412 Cr | ₹315 Cr |
| ₹5276 Cr | ₹3905 Cr | ₹3393 Cr | ₹3235 Cr | ₹3050 Cr | ₹2152 Cr | ₹2037 Cr | ₹1535 Cr | ₹1389 Cr | ₹1200 Cr | ₹1161 Cr | ₹1042 Cr | ₹845 Cr |
| ₹99 Cr | ₹92 Cr | ₹89 Cr | ₹82 Cr | ₹98 Cr | ₹22 Cr | ₹20 Cr | ₹27 Cr | ₹25 Cr | ₹13 Cr | ₹20 Cr | ₹18 Cr | ₹15 Cr |
| ₹73 Cr | ₹14 Cr | ₹492 Cr | ₹537 Cr | ₹358 Cr | ₹97 Cr | ₹175 Cr | ₹269 Cr | ₹173 Cr | ₹195 Cr | ₹213 Cr | ₹255 Cr | ₹166 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹2445 Cr | ₹2252 Cr | ₹1893 Cr | ₹1715 Cr | ₹1542 Cr | ₹1325 Cr | ₹992 Cr | ₹940 Cr | ₹882 Cr | ₹784 Cr | ₹638 Cr | ₹546 Cr | ₹376 Cr |
| ₹989 Cr | ₹854 Cr | ₹702 Cr | ₹617 Cr | ₹521 Cr | ₹421 Cr | ₹348 Cr | ₹288 Cr | ₹232 Cr | ₹181 Cr | ₹137 Cr | ₹101 Cr | ₹72 Cr |
| ₹1456 Cr | ₹1397 Cr | ₹1191 Cr | ₹1097 Cr | ₹1021 Cr | ₹904 Cr | ₹644 Cr | ₹652 Cr | ₹649 Cr | ₹603 Cr | ₹501 Cr | ₹444 Cr | ₹304 Cr |
| ₹177 Cr | ₹160 Cr | ₹195 Cr | ₹103 Cr | ₹31 Cr | ₹17 Cr | ₹57 Cr | ₹0 | ₹0 | ₹0 | ₹7 Cr | ₹0 | ₹22 Cr |
| ₹14 L | ₹14 L | ₹14 L | ₹14 L | ₹39 L | ₹53 L | ₹56 L | ₹9 Cr | ₹12 Cr | ₹4 L | ₹18 Cr | ₹0 | ₹0 |
| ₹14 L | ₹14 L | ₹14 L | ₹14 L | ₹39 L | ₹53 L | ₹56 L | ₹9 Cr | ₹12 Cr | ₹4 L | ₹18 Cr | ₹0 | ₹0 |
| ₹76 Cr | ₹61 Cr | ₹56 Cr | ₹96 Cr | ₹86 Cr | ₹44 Cr | ₹36 Cr | ₹40 Cr | ₹26 Cr | ₹21 Cr | ₹51 Cr | ₹37 Cr | ₹52 Cr |
| ₹7 Cr | ₹9 Cr | ₹10 Cr | ₹14 Cr | ₹20 Cr | ₹29 Cr | ₹50 Cr | ₹99 L | ₹51 L | ₹3 Cr | ₹0 | ₹0 | ₹0 |
| ₹1716 Cr | ₹1631 Cr | ₹1452 Cr | ₹1311 Cr | ₹1159 Cr | ₹995 Cr | ₹787 Cr | ₹702 Cr | ₹688 Cr | ₹626 Cr | ₹580 Cr | ₹481 Cr | ₹378 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹19 Cr | ₹6 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹756 Cr | ₹681 Cr | ₹630 Cr | ₹730 Cr | ₹722 Cr | ₹430 Cr | ₹398 Cr | ₹268 Cr | ₹295 Cr | ₹244 Cr | ₹289 Cr | ₹261 Cr | ₹192 Cr |
| ₹797 Cr | ₹770 Cr | ₹834 Cr | ₹845 Cr | ₹884 Cr | ₹531 Cr | ₹582 Cr | ₹473 Cr | ₹334 Cr | ₹295 Cr | ₹259 Cr | ₹273 Cr | ₹241 Cr |
| ₹1681 Cr | ₹576 Cr | ₹277 Cr | ₹150 Cr | ₹103 Cr | ₹68 Cr | ₹147 Cr | ₹21 Cr | ₹18 Cr | ₹7 Cr | ₹14 Cr | ₹12 Cr | ₹24 Cr |
| ₹24 Cr | ₹32 Cr | ₹30 Cr | ₹15 Cr | ₹9 Cr | ₹10 Cr | ₹13 Cr | ₹8 Cr | ₹4 Cr | ₹4 Cr | ₹6 Cr | ₹6 Cr | ₹4 Cr |
| ₹303 Cr | ₹215 Cr | ₹169 Cr | ₹139 Cr | ₹145 Cr | ₹99 Cr | ₹104 Cr | ₹64 Cr | ₹49 Cr | ₹24 Cr | ₹13 Cr | ₹10 Cr | ₹5 Cr |
| ₹3560 Cr | ₹2275 Cr | ₹1941 Cr | ₹1879 Cr | ₹1864 Cr | ₹1157 Cr | ₹1250 Cr | ₹833 Cr | ₹701 Cr | ₹574 Cr | ₹580 Cr | ₹561 Cr | ₹466 Cr |
| ₹2465 Cr | ₹1381 Cr | ₹730 Cr | ₹613 Cr | ₹592 Cr | ₹577 Cr | ₹520 Cr | ₹308 Cr | ₹221 Cr | ₹157 Cr | ₹184 Cr | ₹149 Cr | ₹151 Cr |
| ₹5276 Cr | ₹3905 Cr | ₹3393 Cr | ₹3235 Cr | ₹3050 Cr | ₹2152 Cr | ₹2037 Cr | ₹1535 Cr | ₹1389 Cr | ₹1200 Cr | ₹1161 Cr | ₹1042 Cr | ₹845 Cr |
| ₹216 | ₹199 | ₹50 | ₹50 | ₹87 | ₹6,801 | ₹5,554 | ₹7,286 | ₹6,763 | ₹6,053 | ₹5,356 | ₹4,204 | ₹3,901 |
| ₹216 | ₹199 | ₹50 | ₹50 | ₹43 | ₹62 | ₹50 | ₹66 | ₹61 | ₹55 | ₹49 | ₹38 | ₹35 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹382 Cr | ₹345 Cr | -₹45 Cr | ₹150 Cr | -₹193 Cr | ₹172 Cr | ₹114 Cr | ₹126 Cr | ₹150 Cr | ₹143 Cr | ₹89 Cr | ₹77 Cr | ₹126 Cr |
| ₹164 Cr | ₹172 Cr | ₹556 Cr | ₹158 Cr | ₹631 Cr | ₹144 Cr | ₹78 Cr | ₹74 Cr | ₹68 Cr | ₹67 Cr | ₹64 Cr | ₹59 Cr | ₹27 Cr |
| ₹722 Cr | ₹30 Cr | ₹50 Cr | -₹34 Cr | -₹352 Cr | -₹137 Cr | -₹115 Cr | -₹172 Cr | -₹13 Cr | -₹16 Cr | -₹11 Cr | -₹45 Cr | -₹135 Cr |
| ₹1269 Cr | ₹546 Cr | ₹561 Cr | ₹274 Cr | ₹87 Cr | ₹179 Cr | ₹77 Cr | ₹28 Cr | ₹204 Cr | ₹194 Cr | ₹141 Cr | ₹90 Cr | ₹17 Cr |
| ₹1181 Cr | ₹465 Cr | ₹498 Cr | ₹177 Cr | ₹32 Cr | ₹134 Cr | ₹28 Cr | -₹23 Cr | ₹157 Cr | ₹156 Cr | ₹89 Cr | ₹72 Cr | -₹15 Cr |
| -₹930 Cr | -₹548 Cr | -₹330 Cr | -₹305 Cr | -₹235 Cr | -₹109 Cr | -₹190 Cr | -₹49 Cr | -₹111 Cr | -₹128 Cr | -₹123 Cr | -₹150 Cr | -₹55 Cr |
| ₹34 Cr | ₹73 Cr | -₹108 Cr | ₹125 Cr | ₹236 Cr | -₹95 Cr | ₹233 Cr | ₹75 Cr | -₹35 Cr | -₹34 Cr | ₹37 Cr | ₹66 Cr | ₹89 Cr |
| ₹285 Cr | -₹10 Cr | ₹60 Cr | -₹4 Cr | ₹33 Cr | -₹70 Cr | ₹71 Cr | ₹3 Cr | ₹11 Cr | -₹7 Cr | ₹4 Cr | -₹11 Cr | ₹18 Cr |
| ₹101 Cr | ₹111 Cr | ₹52 Cr | ₹55 Cr | ₹22 Cr | ₹92 Cr | ₹21 Cr | ₹18 Cr | ₹7 Cr | ₹14 Cr | ₹10 Cr | ₹21 Cr | ₹3 Cr |
| ₹0 | ₹0 | -₹38 L | ₹0 | ₹0 | ₹51 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹386 Cr | ₹101 Cr | ₹111 Cr | ₹52 Cr | ₹55 Cr | ₹22 Cr | ₹92 Cr | ₹21 Cr | ₹18 Cr | ₹7 Cr | ₹14 Cr | ₹10 Cr | ₹21 Cr |
Fundamental Ratios
Consolidated
Standalone

No results found
Akums Drugs & Pharmaceuticals Share Price
769.95+0.65 (+0.08%)
+66.55% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 3 out of 9 oscillators
RSI
46.66Neutral
STOCH %K
34.33Neutral
MACD Level(12,26)
1.84Buy
Ultimate Oscillator
42.73Sell
Aroon Oscillator
66.00Buy
BOP
-0.18Sell
CCI
-94.76Neutral
Williams %R
-65.67Neutral
Momentum
-53.35Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 4
Bearish signals: 5 out of 9 moving averages
EMA 9
780.61Sell
SMA 9
786.77Sell
EMA 21
784.81Sell
SMA 21
795.08Sell
EMA 50
758.74Buy
SMA 50
766.00Buy
EMA 200
634.20Buy
SMA 200
588.35Buy
WMA 20
792.52Sell
Pivot
Pivot
Classic
Resistance 5
917.82
Resistance 4
878.27
Resistance 3
838.72
Resistance 2
799.17
Resistance 1
784.23
Pivot
759.62
Support 1
744.68
Support 2
720.07
Support 3
680.52
Support 4
640.97
Support 5
601.42
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Akums Drugs & Pharmaceuticals Share Price
769.95+0.65 (+0.08%)
+66.55% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 75.26% | 75.26% | 75.26% | 75.26% | 75.26% | 75.26% |
| 4.50% | 1.91% | 1.38% | 1.14% | 2.27% | 4.24% |
| 3.51% | 3.67% | 3.41% | 3.18% | 2.84% | 2.12% |
| 7.58% | 9.77% | 10.95% | 11.23% | 6.44% | 6.73% |
| 9.15% | 9.39% | 9.00% | 9.19% | 13.19% | 11.65% |
Bulk & block deals
Name
Icici Prudential Mutual Fund
Ruby Qc Investment Holdings Pte.ltd.
Icici Prudential Mutual Fund
Ruby Qc Investment Holdings Pte.ltd.
Smallcap World Fund Inc
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 22 Dec 2025 | Purchase | 311.52 Cr | ₹428 | 72.79 L | Bulk | 4.624404 | NSE |
| 22 Dec 2025 | Sell | 311.52 Cr | ₹428 | 72.79 L | Bulk | 4.624404 | NSE |
| 22 Dec 2025 | Purchase | 311.52 Cr | ₹428 | 72.79 L | Block | 4.624404 | NSE |
| 22 Dec 2025 | Sell | 311.52 Cr | ₹428 | 72.79 L | Block | 4.624404 | NSE |
| 06 Aug 2024 | Purchase | 194.98 Cr | ₹753.84 | 25.87 L | Bulk | 1.643354 | NSE |
Insider trading & SAST
Client name
Ruby Qc Investment Holdings Pte Ltd
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06 Jan 2026 | Other | Disposal | 4.62 | — | 0 | — | 72.79 L | 22 Dec 2025 | Block Deal | — | SAST | 29(2) | — |
Akums Drugs & Pharmaceuticals Share Price
769.95+0.65 (+0.08%)
+66.55% past 1 Year
Akums Drugs and Pharmaceuticals is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. As one of the
Corporate Actions
Date
Type
Details
Company details
Akums Drugs & Pharmaceuticals Share Price
769.95+0.65 (+0.08%)
+66.55% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Akums Drugs & Pharmaceuticals Share Price
769.95+0.65 (+0.08%)
+66.55% past 1 Year
News
Akums Drugs And Pharmaceuticals to host analyst and investor meet on 22 Sept
Equity
AKUMS
Akums Drugs And Pharmaceuticals to host analyst and investor meeting on September 2
Equity
AKUMS
Akums Drugs gains as Citi raises FY27–28 EPS estimates on CDMO, API outlook
Equity
AKUMS
Akums Drugs updates Baddi facility to expand oral manufacturing capacity by FY27
Equity
AKUMS
Akums Drugs updates API segment profitability target for FY27 and FY28
Equity
AKUMS
Akums Drugs shares update on Zambia order and Europe launch timeline
Equity
AKUMS
Akums Drugs sees improved domestic branded performance from Q3 FY27
Equity
AKUMS
Akums Drugs guides annual margins at 14% to 15% after strong Q1
Equity
AKUMS
Akums Drugs expects robust FY27 operating performance, CDMO growth stays strong
Equity
AKUMS
Akums Drugs outlines medium-term effective tax roadmap in recent concall update
Equity
AKUMS
Akums Drugs outlines Rs 300 crores capex plan for FY27 expansion
Equity
AKUMS
Akums Drugs sees trade generics business stable, limited impact on group performance
Equity
AKUMS
Akums Drugs guided for reduced API segment losses, targeting positive monthly EBITDA
Equity
AKUMS
Akums Drugs targets double digit growth in domestic branded formulations
Equity
AKUMS
Akums Drugs secures long term European CDMO contract with fixed pricing till 2032
Equity
AKUMS
Akums Drugs announces Zambia CDMO contract with phased FY27-FY28 supplies
Equity
AKUMS
Akums Drugs sees strong H1 FY27 CDMO volume growth with stable margins
Equity
AKUMS
Akums Drugs and Pharmaceuticals inform about update on disruption in operations
Equity
AKUMS
Akums Drugs resumes Haridwar manufacturing; four-day halt delays Rs 20 crore supply
Equity
AKUMS
Akums Drugs & Pharma - Quaterly Results
Equity
AKUMS

